Jay D. Kranzler's most recent trade in Avenue Therapeutics Inc was a trade of 61 COMMON STOCK, PAR VALUE $0.0001 done at an average price of $2.2 . Disclosure was reported to the exchange on Nov. 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avenue Therapeutics Inc | Jay D. Kranzler | Director | Sale of securities on an exchange or to another person at price $ 2.25 per share. | 05 Nov 2024 | 61 | 559 (0%) | 0% | 2.2 | 137 | COMMON STOCK, PAR VALUE $0.0001 |
| Avenue Therapeutics Inc | Jay D. Kranzler | Director | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 27 Sep 2024 | 497 | 620 (0%) | 0% | 2.5 | 1,243 | COMMON STOCK, PAR VALUE $0.0001 |
| Avenue Therapeutics Inc | Jay D. Kranzler | Director | Purchase of securities on an exchange or from another person at price $ 2.33 per share. | 27 Sep 2024 | 3 | 123 (0%) | 0% | 2.3 | 7 | COMMON STOCK, PAR VALUE $0.0001 |
| Avenue Therapeutics Inc | Jay D. Kranzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2024 | 30,000 | 30,000 | - | - | Employee stock option (right to buy) | |
| Avenue Therapeutics Inc | Jay D. Kranzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 100,000 | 100,000 | - | - | Employee stock option (right to buy) |